Access to Vaccines Index homepage
Great diversity in how companies improve vaccines access for people in poorer countries
Adaptations to existing vaccines account for half of vaccine R&D projects
Companies are adapting existing vaccines for low-resource settings. Adaptive projects account for 48% of projects in the pipeline, including many multivalent vaccines.
When setting prices, all companies consider countries’ Gavi status – most also consider GNI per capita
Collectively, the six companies consider 18 diverse factors when setting vaccine prices.
News related to the Access to Vaccines Index
"There have been massive improvements in global health in the past decades, with all major pharmaceutical companies taking action. To close the gaps that remain, a greater diversity of companies must get involved and stay engaged."
Jayasree K. Iyer
Executive Director Access to Medicine Foundation
View our detailed overview of each company’s performance in the Index